ARCHIVES

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

European Commission Approves Subcutaneous Rituximab

March 28, 2014

In Brief: Visco Elected Chairman of DOD Panel; Breast Cancer Stamp Raises $4.9 Million

February 19, 1999

After 30 Years As NCI-Designated Center, Vermont Cancer Center Loses Core Grant.

November 14, 2008

Senate Confirms McClellan For FDA

October 25, 2002

In Brief: NCAB To Meet Jan. 15-17; UCLA To Compete For Clinical Neutron Therapy Contract

January 5, 1979

GAO Suggests No Limit On Indirect Costs But Ceiling On Total Costs

September 7, 1979